Policy changes Backwork has recorded, newest first. The most recent change on record is from October 2, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,180 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Intestinal Transplantation | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Intensive Outpatient Pediatric Feeding Program | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Intensity-Modulated Radiotherapy (IMRT) of the Breast and Lung | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Inotersen (Tegsedi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Trigger Point Injections | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ingestible pH and Pressure Capsule | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Infliximab Products: Infliximab (Remicade); Infliximab axxq (Avsola), Infliximab dyyb (Inflectra); Infliximab abda (Renflexis); Infliximab-dyyb (Zymfentra), Infliximab | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Inebilizumab-cdon (Uplizna) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Inclisiran (Leqvio) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | IncobotulinumtoxinA(Xeomin) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | In Vitro Particle Size Measurement for Screening Hypersensitivity Reactions to Foods and Chemicals | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | DESCRIPTION | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Steroid-Eluting and Non-Steroid-Eluting Sinus Stents | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Talimogene Laherparepvec (Imlygic) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tremelimumab-actl (Imjudo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Imetelstat (Rytelo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tarlatamab-dlle (Imdelltra) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nipocalimab-aahu (Imaavy) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Tildrakizumab-asmn (Ilumya) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Image-Guided Minimally Invasive Decompression for Spinal Stenosis | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Travoprost Intracameral Implant (iDose TR) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ibalizumab-uiyk (Trogarzo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Hospital-Grade Breast Pump | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Home Spirometry | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Home Apnea Monitoring / Home Cardiorespiratory Monitoring | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Histrelin Acetate (Supprelin LA) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Hippotherapy | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Trastuzumab Products (Herceptin, Ontruzant, Herzuma, Ogivri, Trazimera, Kanjinti, Hercessi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Hematopoietic Stem-Cell Transplantation for Miscellaneous Solid Tumors in Adults | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Hair Transplantation | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Guselkumab (Tremfya) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Goserelin Acetate (Zoladex) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Golodirsen (Vyondys-53) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Golimumab (Simponi ARIA) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Givosiran (Givlaari) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for Warfarin Dose | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for Mitochondrial Disorders | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related Connective Tissue Disorders | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for Lipoprotein(a) Variant(s) as a Decision Aid for Aspirin Treatment | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Novel Biomarkers for the Diagnosis and Management of Prostate Cancer | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for Mental Health Conditions | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Gene Expression Profile Analysis for Prostate Cancer Management | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Gender Reassignment Surgery | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Gemtuzumab Ozogamicin (Mylotarg) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Gemcitabine (Inlexzo) intravesical system | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | DOCUMENTATION | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Galsulfase (Naglazyme) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Sirolimus protein-bound particles for injectable suspension (albumin-bound) (Fyarro) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Fractional Laser Treatment of Vulvovaginal Atrophy | Metadata changed |